Lionco Pharmaceutical Group Co (SHSE:603669) E10: ¥0.04 (As of Mar. 2026)


SHSE:603669 Lionco Pharmaceutical Group Co Ltd SHSE:603669
46 GF Score
Price ¥6.04
GF Value ¥6.81
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Lionco Pharmaceutical Group Co E10?

Lionco Pharmaceutical Group Co SHSE:603669 -0.33% 46 E10 is ¥0.04 as of Mar. 2026. GuruFocus rates SHSE:603669 with a GF Score™ of 46/100 and a GF Value™ of ¥6.81 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Lionco Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥0.004. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.04 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Lionco Pharmaceutical Group Co's average E10 Growth Rate was -55.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-08), Lionco Pharmaceutical Group Co's current stock price is ¥6.04. Lionco Pharmaceutical Group Co's E10 for the quarter that ended in Mar. 2026 was ¥0.04. Lionco Pharmaceutical Group Co's Shiller PE Ratio of today is 151.00.

During the past 13 years, the highest Shiller PE Ratio of Lionco Pharmaceutical Group Co was 153.00. The lowest was 21.93. And the median was 44.37.


Lionco Pharmaceutical Group Co  (SHSE:603669) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lionco Pharmaceutical Group Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=6.04/0.04
=151.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Lionco Pharmaceutical Group Co was 153.00. The lowest was 21.93. And the median was 44.37.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Lionco Pharmaceutical Group Co E10 Related Terms


Lionco Pharmaceutical Group Co E10 Historical Data

* Premium members only.

The historical data trend for Lionco Pharmaceutical Group Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lionco Pharmaceutical Group Co E10 Chart

Lionco Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.15 0.10 0.05

Lionco Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.08 0.08 0.05 0.04

SHSE:603669 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lionco Pharmaceutical Group Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lionco Pharmaceutical Group Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lionco Pharmaceutical Group Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lionco Pharmaceutical Group Co's Shiller PE Ratio falls into.


SHSE:603669
46GF Score
Lionco Pharmaceutical Group Co Ltd SHSE:603669
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lionco Pharmaceutical Group Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lionco Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.004/116.3033*116.3033
=0.004

Current CPI (Mar. 2026) = 116.3033.

Lionco Pharmaceutical Group Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.066 101.400 0.076
201609 0.040 102.400 0.045
201612 0.073 102.600 0.083
201703 0.040 103.200 0.045
201706 0.042 103.100 0.047
201709 0.051 104.100 0.057
201712 0.087 104.500 0.097
201803 0.046 105.300 0.051
201806 0.054 104.900 0.060
201809 0.136 106.600 0.148
201812 0.021 106.500 0.023
201903 0.050 107.700 0.054
201906 0.100 107.700 0.108
201909 0.060 109.800 0.064
201912 0.070 111.200 0.073
202003 0.090 112.300 0.093
202006 0.020 110.400 0.021
202009 0.110 111.700 0.115
202012 0.000 111.500 0.000
202103 0.050 112.662 0.052
202106 0.040 111.769 0.042
202109 0.010 112.215 0.010
202112 -0.020 113.108 -0.021
202203 0.030 114.335 0.031
202206 0.020 114.558 0.020
202209 -0.150 115.339 -0.151
202212 -0.170 115.116 -0.172
202303 -0.030 115.116 -0.030
202306 -0.070 114.558 -0.071
202309 -0.030 115.339 -0.030
202312 -0.080 114.781 -0.081
202403 -0.020 115.227 -0.020
202406 -0.040 114.781 -0.041
202409 -0.005 115.785 -0.005
202412 -0.115 114.893 -0.116
202503 -0.026 115.116 -0.026
202506 -0.024 114.907 -0.024
202509 0.002 115.471 0.002
202512 -0.222 115.832 -0.223
202603 0.004 116.303 0.004

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.04 mean?
Lionco Pharmaceutical Group Co (SHSE:603669) has a E10 of ¥0.04 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Lionco Pharmaceutical Group Co and its competitors.
Is Lionco Pharmaceutical Group Co's E10 too high?
Lionco Pharmaceutical Group Co's current E10 is ¥0.04. Overall, Lionco Pharmaceutical Group Co has a GF Score™ of 46/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lionco Pharmaceutical Group Co's E10 compare to ZTS and UTHR?
Lionco Pharmaceutical Group Co's E10 of ¥0.04 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Lionco Pharmaceutical Group Co and its competitors. Lionco Pharmaceutical Group Co's current E10 is ¥0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lionco Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Lionco Pharmaceutical Group Co (SHSE:603669) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥6.81, compared to a current price of ¥6.04 — trading 11.3% below its estimated fair value. The current E10 is ¥0.04. Lionco Pharmaceutical Group Co's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Lionco Pharmaceutical Group Co (SHSE:603669), the current E10 is ¥0.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lionco Pharmaceutical Group Co (SHSE:603669) Overvalued in 2026?

Based on GuruFocus' analysis, Lionco Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥6.04 is trading 11.3% below its estimated GF Value™ of ¥6.81. GuruFocus considers Lionco Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:603669:

  • E10: ¥0.04
  • GF Value™: ¥6.81 vs. price of ¥6.04 (11.3% below fair value)
  • GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lionco Pharmaceutical Group Co Business Description

Address No. 20, National Highway 349, Naidong District, Shannan, CHN
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
46GF Score

Get the complete analysis for SHSE:603669

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.04
Price
¥6.81
GF Value